IP Library Granted Patent US 7,723,031
Granted Patent B2
US 7,723,031 · App. 11/204,125 · Granted May 25, 2010

Methods for nucleic acid manipulation

Assignee: ThePenn State Research Foundation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,723,031
App. No.
11/204,125
Granted
May 25, 2010
Kind
B2
Abstract

A method for replicating and amplifying a target nucleic acid sequence is described. A method of the invention involves the formation of a recombination intermediate without the prior denaturing of a nucleic acid duplex through the use of a recombination factor. The recombination intermediate is treated with a high fidelity polymerase to permit the replication and amplification of the target nucleic acid sequence. In preferred embodiments, the polymerase comprises a polymerase holoenzyme. In further preferred embodiments, the recombination factor is bacteriophage T4 UvsX protein or homologs from other species, and the polymerase holoenzyme comprises a polymerase enzyme, a clamp protein and a clamp loader protein, derived from viral, bacteriophage, prokaryotic, archaebacterial, or eukaryotic systems.

Claims (11)

1. A method for amplifying a target nucleic acid sequence comprising reacting said nucleic acid with two primers that are complementary to the flanking ends of said target nucleic acid sequence within a nucleic acid duplex, said reaction being carried out in the presence of a bacteriophage UvsX protein, bacteriophage UvsY protein, and a DNA polymerase having a proofreading/editing function, without previously denaturing said nucleic acid duplex, wherein said nucleic acid, primers and bacteriophase UvsX protein form a recombination intermediate and said polymerase combines with said recombination intermediate to form a polymerase complex.

2. The method according to claim 1 wherein said DNA polymerase is a gene product of a viral, bacteriophage, prokaryotic, or eukaryotic system.

3. The method according to claim 2 wherein said DNA polymerase is a gene product of bacteriophage T4.

4. The method according to claim 1 wherein said DNA polymerase is a holoenzyme complex.

5. The method according to claim 4 wherein said DNA polymerase holoenzyme complex is a gene product of a viral, bacteriophage, prokaryotic, or eukaryotic system.

6. The method according to claim 5 wherein said DNA polymerase holoenzyme complex comprises a polymerase enzyme, a clamp protein, and a clamp loader.

7. The method according to claim 5 wherein said DNA polymerase is a gene product of bacteriophage T4.

8. The method according to claim 1 wherein said method is carried out in the presence of a single stranded nucleic acid binding protein.

9. The method according to claim 1 wherein said method is carried out in the presence of a helicase.

10. The method according to claim 9 wherein said method is carried out in the presence of a helicase accessory factor.

11. The method according to claim 1 wherein said method is carried out in the presence of an ATP regeneration system.

Assignments (3)
CONFIRMATORY LICENSE Recorded Dec 9, 2011
From: THE PENNSYLVANIA STATE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 027357/0599 →
CONFIRMATORY LICENSE Recorded Oct 24, 2008
From: THE GEORGE WASHINGTON UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021734/0872 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 3, 2005
From: BENKOVIC, STEPHEN J.; SALINAS, FRANK
To: PENN STATE RESEARCH FOUNDATION, THE
Reel/Frame 017255/0067 →
Continuity (3)
Continuation 1012597300 · Apr 19, 2002
Provisional Application 6028512700 · Apr 20, 2001
Related Publication 20060292582A1 · Dec 28, 2006